Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients

NCT02684643 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT02684643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02684643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2016
Completion date
April 30, 2017
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease, hyperphosphatemia